Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of prucalopride to evaluate anti-inflammatory effects in patients undergoing pancreatoduodenectomy
2014-000361-52Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of prucalopride in Pancreatic neoplasia, sponsored by KU Leuven. Primary endpoint: Inflammatory parameters in blood. Started Feb 2014; status: completed.
02
Drugs
prucalopride
03
Conditions
Pancreatic neoplasia
Beyond the preview
Go deeper on 2014-000361-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000361-52.